This post was originally published on this site
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) 33% HIGHER; provided an update on injection kits supplied by Apellis and an update on the rare events of retinal vasculitis reported in real-world treatment with SYFOVRE® (pegcetacoplan injection) for geographic atrophy (GA) secondary to age-related macular degeneration (AMD).
Urban Outfitters (NASDAQ:URBN) 4% HIGHER; reported Q2 EPS of $1.10, $0.21 better than the analyst estimate of $0.89. Revenue for the quarter came in at $1.27 billion versus the consensus estimate of $1.25B.
La-Z-Boy Incorporated (NYSE:LZB) 1% LOWER; reported Q1 EPS of $0.62, $0.08 better than the analyst estimate of $0.54. Revenue for the quarter came in at $482 million versus the consensus estimate of $476.2M. La-Z-Boy sees Q2 2024 revenue of $490-510M.
Toll Brothers (NYSE:TOL) 1% HIGHER; reported Q3 EPS of $3.73, $0.89 better than the analyst estimate of $2.84. Revenue for the quarter came in at $2.69B versus the consensus estimate of $2.4B.
